NovoCure Limited (NVCR) Gross profit 2017–2026
NovoCure Limited (NVCR) annual gross profit history from SEC filings — each fiscal year as reported.
$488.5MFY2026 · since FY2017: $36.6M → $488.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $488.5M | +4.4% |
| FY2025 | $468.0M | +22.8% |
| FY2024 | $381.1M | -9.9% |
| FY2023 | $423.0M | +0.7% |
| FY2022 | $420.2M | +8.3% |
| FY2021 | $387.9M | +47.6% |
| FY2020 | $262.7M | +56.4% |
| FY2019 | $168.0M | +38.4% |
| FY2018 | $121.4M | +231.7% |
| FY2017 | $36.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice